0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT00257738 · COMPLETED

Trial details

NCT number: NCT00257738
Sponsor: University of Maryland, Baltimore
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2005-11-01
Primary completion: 2012-10-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.